Plasmalogen loss caused by remodeling deficiency in mitochondria

Area of Science:

• Biochemistry
• Cell Biology
• Mitochondrial Biology

Background:

• Lipid homeostasis is vital for human health.
• Barth syndrome (BTHS) is a severe genetic disorder caused by tafazzin mutations, leading to cardiomyopathy and neutropenia.
• Tafazzin localizes to the inner mitochondrial membrane and is crucial for cardiolipin (CL) and phosphatidylethanolamine metabolism.

Purpose of the Study:

• To investigate the impact of tafazzin deficiency on plasmalogen levels in various tissues beyond the heart.
• To understand the cell type-specific effects of tafazzin dysfunction on lipid homeostasis.
• To explore the potential link between tafazzin-related plasmalogen loss and other neurodegenerative diseases.

Main Methods:

• Utilized high-resolution 31P nuclear magnetic resonance (NMR) with cryoprobe technology.
• Analyzed tissue samples (heart, brain, liver, kidney) and lymphoblasts from tafazzin-knockdown (TAZ-KD) models and BTHS patients compared to controls.
• Focused on quantifying plasmalogen and cardiolipin alterations.

Main Results:

• Confirmed significant loss of choline plasmalogen in TAZ-KD mouse hearts, alongside known cardiolipin alterations.
• Identified cell type-dependent, but common, losses of ethanolamine plasmalogen in TAZ-KD brain, liver, kidney, and lymphoblasts.
• Demonstrated that tafazzin critically regulates plasmalogen homeostasis, particularly the ethanolamine class.

Conclusions:

• Tafazzin deficiency leads to widespread plasmalogen loss, affecting mitochondrial integrity and function.
• Ethanolamine plasmalogens play critical roles in mitochondria, potentially analogous to diacyl phosphatidylethanolamine.
• Disruption of plasmalogen-protein interactions due to plasmalogen loss may contribute to pathologies in BTHS and other conditions like Alzheimer's disease.